CANTREAT is not a new drug, but rather a precisely targeted medical device. Our magnetically controlled nanoparticles deliver approved cytostatic drugs directly into the tumor. They function like a “Trojan horse”: the tumor identifies the nanoparticle's protective shell as an energy source, absorbs it, and thereby activates the chemotherapy directly within the tumor cells.
Approved and clinically proven cytostatic drugs are utilized. However, the CANTREAT method ensures significantly greater precision, drastically reducing side effects and greatly enhancing the effectiveness of chemotherapy.
Nanoparticles are injected into the artery supplying blood to the tumor.
An external magnet precisely positions and concentrates the nanoparticles within the tumor tissue.
The tumor enzymatically dissolves the nanoparticle shell, releasing the cytostatic drug directly inside the tumor cells.
After successful drug delivery, nanoparticles are safely eliminated from the body.
